Chu Dijon Bourogne
Dijon, 21000, France
NCT Number: NCT04672343
Mortality due to Covid-19 is much higher in the elderly. There are several reasons for the vulnerability of the elderly to the coronavirus: a less efficient immune system, underlying chronic conditions, less protected living conditions. They may also present a poor nutritional state and/or degraded metabolic reserves aggravating an underlying state of frailty. The prevalence of the risk of undernutrition in elderly patients with COVID-19 is high. The evolution of the nutritional status of people aged 70 years or older infected with SARS-Cov-2 is not yet well known. The prognosis of these patients could depend on their nutritional status at the time of the disease. In view of the lack of data, it would be interesting to compare the risk of mortality based on nutritional status in individuals with vs. those without COVID-19.
Looking for future studies?
Notify Me70 year and older
All sexes
Observational
Dijon, 21000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
from D0 to hospital discharge
Vital status at 3 months and 12 months
Time frame: to 3 months
Centre Hospitalier Universitaire Dijon
Other
IPrognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2
Acronym: CodePRONUT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07720596
COVID-19, Coronaviridae Infections
Prague, Czechia
View Trial DetailsNCT06743334
COVID-19, Coronaviridae Infections
Seoul, South Korea
View Trial DetailsNCT05876377
COVID-19, Chronic Disease
New York, United States
View Trial DetailsNCT04337424
SARS-CoV-2
Montpellier, France
View Trial Details